SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-Q/A - Quarterly report [Sections 13 or 15(d)]: [Amend]
SEC Accession No. 0001193125-04-102681
Filing Date
2004-06-14
Accepted
2004-06-14 16:52:14
Documents
6
Period of Report
2003-09-30

Document Format Files

Seq Description Document Type Size
1 FORM 10-Q/A d10qa.htm 10-Q/A 195380
2 LICENSE AGREEMENT dex1039.htm EX-10.39 139374
3 CERTIFICATE dex311.htm EX-31.1 9437
4 CERTIFICATE dex312.htm EX-31.2 9563
5 CERTIFICATE dex321.htm EX-32.1 2769
6 CERTIFICATE dex322.htm EX-32.2 2867
  Complete submission text file 0001193125-04-102681.txt   361533
Mailing Address 8540 COLONNADE CENTER DR SUITE 501 RALEIGH NC 27615
Business Address 8540 COLONNADE CENTER DR SUITE 501 RALEIGH NC 27615 9198621000
SALIX PHARMACEUTICALS LTD (Filer) CIK: 0001009356 (see all company filings)

IRS No.: 943267443 | Fiscal Year End: 1231
Type: 10-Q/A | Act: 34 | File No.: 000-23265 | Film No.: 04861949
SIC: 2834 Pharmaceutical Preparations